secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENXBIO Inc. (RGNX)
CIK:        0001590877
Form:       8-K
Filed at:   2026-07-20T11:34:30+00:00
Accession:  0001193125-26-308342
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

REGENXBIO prices $100M public offering of common stock and pre-funded warrants
------------------------------------------------------------------------------

- Offering of 10,003,889 shares at $9.00/share and 1,111,111 pre-funded warrants at $8.9999 each.
- Gross proceeds ~$100M; net proceeds ~$107.8M after underwriters' full exercise of 1,667,250 option shares.
- Underwriters: Morgan Stanley, J.P. Morgan, Leerink Partners, Mizuho Securities.
- Expected to close July 20, 2026, subject to customary conditions.
- Pre-funded warrants have $0.0001 exercise price, exercisable immediately, no expiration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1590877/000119312526308342/0001193125-26-308342-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1590877/000119312526308342/d40931d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-308342

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer